Marquette Asset Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Marquette Asset Management’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-78,551	Closed	-$54.9K	–	308
2023 Q1	$54.9K	Hold	78,551	–	–	0.01%	143
2022 Q4	$70.7K	Buy	+78,551	New	+$228K	0.02%	136

Marquette Asset Management's STSA Position: Q2 2023 in Review

Marquette Asset Management sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 78,551 shares — an estimated $54.9K sold.

Marquette Asset Management first reported a position in STSA in Q4 2022 and held it in 2 quarters. The position peaked at $70.7K in Q4 2022. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Marquette Asset Management reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Marquette Asset Management sold 78,551 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $54.9K.
Marquette Asset Management first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Marquette Asset Management's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $70.7K in Q4 2022.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Marquette Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.